Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Interest Expenses (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Interest Expenses data on record, last reported at -$236000.0 in Q4 2025.

  • For Q4 2025, Interest Expenses fell 286.89% year-over-year to -$236000.0; the TTM value through Dec 2025 reached -$2.3 million, down 247.73%, while the annual FY2025 figure was -$2.3 million, 247.73% down from the prior year.
  • Interest Expenses reached -$236000.0 in Q4 2025 per ORGO's latest filing, up from -$415000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $2.5 million in Q1 2021 and bottomed at -$961000.0 in Q1 2025.
  • Average Interest Expenses over 5 years is $534850.0, with a median of $543000.0 recorded in 2022.
  • Peak YoY movement for Interest Expenses: skyrocketed 1773.33% in 2023, then tumbled 286.96% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $853000.0 in 2021, then tumbled by 103.52% to -$30000.0 in 2022, then surged by 1773.33% to $502000.0 in 2023, then crashed by 112.15% to -$61000.0 in 2024, then plummeted by 286.89% to -$236000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were -$236000.0 in Q4 2025, -$415000.0 in Q3 2025, and -$669000.0 in Q2 2025.